PharmaCielo Ltd. (TSXV:PCLO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0550
0.00 (0.00%)
Mar 6, 2026, 12:28 PM EST
-31.25%
Market Cap 10.34M
Revenue (ttm) 1.75M
Net Income (ttm) -4.65M
Shares Out 187.98M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,636
Average Volume 95,700
Open 0.0550
Previous Close 0.0550
Day's Range 0.0550 - 0.0550
52-Week Range 0.0250 - 0.1650
Beta 0.16
RSI 43.29
Earnings Date Mar 18, 2026

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered ... [Read more]

Sector Healthcare
CEO Marc Lustig
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol PCLO
Full Company Profile

Financial Performance

In fiscal year 2025, PharmaCielo's revenue was 3.17 million, a decrease of -8.81% compared to the previous year's 3.48 million. Losses were -9.10 million, -0.50% less than in 2024.

Financial Statements

News

There is no news available yet.